PREVALENCIA, PERFIL CLÍNICO Y MANEJO TERAPÉUTICO DEL PACIENTE CON COLITIS ULCEROSA (CU) EN SERVICIOS HOSPITALARIOS DE GASTROENTEROLOGÍA DE ESPAÑA.

Datos básicos

Protocolo:
ABB-TCU-2012-01
EUDRACT:
NCT:
Centro:
HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
Año de incio:
2013
Año de finalización:
2013
ESTUDIO OBSERVACIONAL NACIONAL

Objetivos del proyecto

Observaciones: Estado Comité: FINALIZADO

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

ABBVIE SPAIN SLU

Resultados del Ensayo Clínico


[Peripheral arterial thromboembolism in Crohn's disease].

Ferrer I; (...); Nos P

Abstract of Published Item. 10.1016/j.gastrohep.2012.04.011. 2013


A genome-wide association study on a southern European population identifies a new Crohn's disease susceptibility locus at RBX1-EP300.

Julià A; (...); Marsal S

Article. 10.1136/gutjnl-2012-302865. 2013


Adalimumab in prevention of postoperative recurrence of Crohn's disease in high-risk patients.

Aguas M; (...); Nos P

Article. 10.3748/wjg.v18.i32.4391. 2012


Assessing an improved protocol for plasma microRNA extraction.

Moret I; (...); Beltrán B

Article. 10.1371/journal.pone.0082753. 2013

  • Open Access.

Characteristics and treatment of pyoderma gangrenosum in inflammatory bowel disease.

Argüelles-Arias F; (...); Herrerías-Gutiérrez JM

Article. 10.1007/s10620-013-2762-2. 2013


Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel disease.

Iborra M; (...); Danese S

Article. 10.1111/cei.12104. 2013


Mucosal healing restores normal health and quality of life in patients with inflammatory bowel disease.

Casellas F; (...); Borruel N

Article. 10.1097/MEG.0b013e32835414b2. 2012


Observational study on the efficacy of adalimumab for the treatment of ulcerative colitis and predictors of outcome.

García-Bosch O; (...); Panés J

Article. 10.1016/j.crohns.2012.10.004. 2013


Oral locally active steroids in inflammatory bowel disease.

Nunes T; (...); Sans M

Article. 10.1016/j.crohns.2012.06.010. 2013


Safety of thiopurine therapy in inflammatory bowel disease: long-term follow-up study of 3931 patients.

Chaparro M; (...); Gisbert JP

Article. 10.1097/MIB.0b013e318281f28f. 2013


Smoking does influence disease behaviour and impacts the need for therapy in Crohn's disease in the biologic era.

Nunes T; (...); Panés J

Article. 10.1111/apt.12440. 2013


Study of the Viral and Microbial Communities Associated With Crohn's Disease: A Metagenomic Approach

Perez-Brocal, Vicente; (...); Moya, Andres

Article. 10.1038/ctg.2013.9. 2013

  • Open Access.

Campos de Estudio

Compartir